| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213879 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 27 Pages |
Abstract
Patients with early unfavorable HL have excellent outcomes with 4 cycles of ABVD chemotherapy followed by ISRT. Six cycles of chemotherapy does not appear superior for disease control, even for bulky disease.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jillian R. MD, PhD, Michelle A. MD, Jay P. MD, PhD, Mani MD, Grace L. MD, PhD, Chelsea C. MD, PhD, Sarah A. MD, Zeinab Abou MD, Pamela K. PhD, Eleanor M. MD, Osama PhD, Bouthaina S. MD,